Cart summary

You have no items in your shopping cart.

Orientin

SKU: orb1222416

Description

Orientin may be regarded as a candidate therapeutic agent for treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway. Orientin protects vascular barrier integrity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases. Orientin has neuroprotection effect by the intracellular mediation of caspase activity; may alleviate cognitive deficits and oxidative stress in AD mice; can exert antidepressant-like effects on CUMS mice, specifically by improving central oxidative stress, neurotransmission, and neuroplasticity.

Images & Validation

Key Properties

CAS Number28608-75-5
MW448.38
Purity>98% (HPLC)
FormulaC21H20O11
SMILESC1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4C(C(C(C(O4)CO)O)O)O)O)O
TargetCOX
SolubilityIn Vitro: DMSO : 31.25 mg/mL (69.70 mM)

Bioactivity

In Vivo
Animal model: PCA mouse model. Dosage: 0.1–10 mg/kg. Administration: Oral gavage (p.o.); Euthanized mouse after 1 h. Result: Significantly suppressed PCA reactions in PCA mouse model. Animal model: SNL rat model. Dosage: 10, 20, 40 mg/kg. Administration: Intraperitoneal injection (i.p.); Once daily for 12 days. Result: Alleviated the downreg-ulation of PWL and promoted the behavior recovery in SNL rat model. Decreased the levels of IL-6, IL-1β and TNF-α. Increased the level of anti-inflammatory IL-10. Down-regulated the level of MDA.
In Vitro
Cell Viability Assay Cell line: RBL-2H3, mBMMCs, and RPMCs. Concentration: 0.01-100 μM Incubation time: 8 h. Result: Significantly suppressed the levels of histamine and β-hexosaminidase in RBL-2H3, mBMMCs, and RPMCs cells. Inhibited the intracellular calcium levels in RBL-2H3, mBMMCs, and RPMCs cells. Markedly inhibited the pro-inflammatory cytokines expression and secretion in RBL-2H3 cells. Inhibited phosphorylation in RBL-2H3 cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Orientin | Lutexin

Similar Products

  • Orientin (Standard) [orb3139958]

    28608-75-5

    448.38

    C21H20O11

    25 mg
  • Orientin 2''-O-p-trans-coumarate [orb1684355]

    73815-15-3

    594.52

    C30H26O13

    10 mg
  • Orientin 2''-O-rhamnoside [orb1681207]

    81398-30-3

    594.522

    C27H30O15

    5 mg
  • Orientin-2''-O-p-trans-coumarate [orb1684354]

    >99.99% (May vary between batches)

    1229437-75-5

    594.52

    C30H26O13

    1 mg, 5 mg, 10 mg
  • Orientin [orb1300241]

    99.96% (May vary between batches)

    28608-75-5

    448.38

    C21H20O11

    1 ml x 10 mM (in DMSO), 50 mg, 25 mg, 100 mg, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Orientin (orb1222416)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
200 mg
500 mg
10 mg
$ 150.00
25 mg
$ 240.00